No abstract available
MeSH terms
-
Animals
-
Arterial Occlusive Diseases / complications
-
Arterial Occlusive Diseases / drug therapy
-
Brain Ischemia / drug therapy*
-
Brain Ischemia / etiology*
-
Europe / epidemiology
-
Fibrinolytic Agents / standards
-
Fibrinolytic Agents / therapeutic use
-
Forecasting
-
Heparin / supply & distribution
-
Heparin / therapeutic use
-
Humans
-
Infusions, Intra-Arterial
-
Infusions, Intravenous
-
Middle Cerebral Artery / pathology
-
Practice Guidelines as Topic
-
Stroke / drug therapy*
-
Stroke / etiology*
-
Thrombolytic Therapy* / standards
-
Tissue Plasminogen Activator / standards
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Outcome
-
United States / epidemiology
-
United States Food and Drug Administration
Substances
-
Fibrinolytic Agents
-
Heparin
-
Tissue Plasminogen Activator